Galena Biopharma fka GALE

[Euripides90]

http://www.smarteranalyst.com/2016/11/03/company-update-nasdaqgale-galena-biopharma-inc-appoints-stephen-f-ghiglieri-executive-vice-president-chief-financial-officer/

“I am excited to be joining Galena at this important time in the Company’s history. Galena is currently re-focusing its efforts with a backbone of valuable hematology and immunotherapy assets. I welcome the opportunity to join the team and provide guidance and leadership to help advance the company through its next stages of development. I believe we have the opportunity to build significant shareholder value by executing on a relatively lower risk clinical and regulatory development program with GALE-401 and supporting ongoing investigator and partner sponsored studies with our immunotherapy assets,” commented, Mr. Ghiglieri.

"relatively lower risk" than all or nothing driving blind? He can't do worse as far as the science goes, and pricewise despite shorts doing their best to keep killing this stock, Zachs has a BUY, and they don't intend to drop dead just yet, reports of their demise are premature.
(The partners referred to include Roche's combo trial with Neuvax and Dr. Reddy's trials in India.)

Here's another smart decision by former Galena top management:
I guess the universally applicable and highly lucrative, relatively low R & D scar treatment market was too risky.

The company was spun out of Galena Pharmaceuticals (NASDAQ:GALE) in 2012.

http://seekingalpha.com/article/4018845-rxi-pharmaceuticals-moving-promising-scar-treatment